Page last updated: 2024-08-21

pyrazines and macitentan

pyrazines has been researched along with macitentan in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	6 (66.67)	24.3611
2020's	3 (33.33)	2.80

Authors

Authors	Studies
Kovacs, G; Olschewski, H	1
Morrell, N; Sitbon, O	1
Channick, RN; Tamura, Y	1
Horn, EM; Krishnan, U	1
Adams, H; Prior, DL; Williams, TJ	1
Furukawa, A; Goto, M; Iwahori, H; Kawamura, A; Ohashi, N; Okabe, T; Tamura, Y	1
Burki, TK	1
Chin, KM; Doelberg, M; Feldman, J; Galiè, N; Gibbs, JSR; Grünig, E; Hoeper, MM; Martin, N; Mathai, SC; McLaughlin, VV; Perchenet, L; Poch, D; Saggar, R; Simonneau, G; Sitbon, O	1
Avdeev, SN; Nekludova, GV; Proshkina, AA; Tsareva, NA	1

Reviews

4 review(s) available for pyrazines and macitentan

Article	Year
Pathways in pulmonary arterial hypertension: the future is here. European respiratory review : an official journal of the European Respiratory Society, 2012, Dec-01, Volume: 21, Issue:126 Topics: Acetamides; Animals; Antihypertensive Agents; Benzamides; Clinical Trials as Topic; Drugs, Investigational; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Epoprostenol; Guanylate Cyclase; Humans; Hypertension, Pulmonary; Imatinib Mesylate; Lisuride; Nitric Oxide; Phosphodiesterase 5 Inhibitors; Piperazines; Protein Kinase Inhibitors; Pyrazines; Pyrazoles; Pyrimidines; Serotonin Antagonists; Sulfonamides	2012
New paradigm for pulmonary arterial hypertension treatment. Current opinion in pulmonary medicine, 2016, Volume: 22, Issue:5 Topics: Acetamides; Antihypertensive Agents; Clinical Trials as Topic; Endothelin Receptor Antagonists; Humans; Hypertension, Pulmonary; Inositol 1,4,5-Trisphosphate Receptors; Phenylpropionates; Phosphodiesterase 5 Inhibitors; Pyrazines; Pyridazines; Pyrimidines; Randomized Controlled Trials as Topic; Sulfonamides	2016
A Contemporary Approach to Pulmonary Arterial Hypertension. Current atherosclerosis reports, 2016, Volume: 18, Issue:9 Topics: Acetamides; Antihypertensive Agents; Endothelin Receptor Antagonists; Humans; Hypertension, Pulmonary; Pyrazines; Pyrimidines; Sulfonamides	2016
Update on pharmacotherapy for pulmonary hypertension. The Medical journal of Australia, 2016, Sep-19, Volume: 205, Issue:6 Topics: Acetamides; Antihypertensive Agents; Australia; Drug Therapy, Combination; Humans; Hypertension, Pulmonary; Pyrazines; Pyrazoles; Pyrimidines; Sulfonamides; World Health Organization	2016

Trials

2 trial(s) available for pyrazines and macitentan

Article	Year
Pharmacotherapy for pulmonary arterial hypertension. The Lancet. Respiratory medicine, 2020, Volume: 8, Issue:11 Topics: Acetamides; Adult; Aged; Antihypertensive Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pulmonary Arterial Hypertension; Pyrazines; Pyrimidines; Severity of Illness Index; Sulfonamides; Tadalafil; Treatment Outcome; Vascular Resistance	2020
Three- Versus Two-Drug Therapy for Patients With Newly Diagnosed Pulmonary Arterial Hypertension. Journal of the American College of Cardiology, 2021, 10-05, Volume: 78, Issue:14 Topics: Acetamides; Adult; Aged; Antihypertensive Agents; Double-Blind Method; Drug Therapy, Combination; Endothelin Receptor Antagonists; Female; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Pulmonary Arterial Hypertension; Pyrazines; Pyrimidines; Sulfonamides; Tadalafil	2021

Article

Year

Pharmacotherapy for pulmonary arterial hypertension.

The Lancet. Respiratory medicine, 2020, Volume: 8, Issue:11

Topics: Acetamides; Adult; Aged; Antihypertensive Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pulmonary Arterial Hypertension; Pyrazines; Pyrimidines; Severity of Illness Index; Sulfonamides; Tadalafil; Treatment Outcome; Vascular Resistance

2020

Three- Versus Two-Drug Therapy for Patients With Newly Diagnosed Pulmonary Arterial Hypertension.

Journal of the American College of Cardiology, 2021, 10-05, Volume: 78, Issue:14

Topics: Acetamides; Adult; Aged; Antihypertensive Agents; Double-Blind Method; Drug Therapy, Combination; Endothelin Receptor Antagonists; Female; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Pulmonary Arterial Hypertension; Pyrazines; Pyrimidines; Sulfonamides; Tadalafil

2021

Other Studies

3 other study(ies) available for pyrazines and macitentan

Article	Year
[Pulmonary hypertension]. Deutsche medizinische Wochenschrift (1946), 2012, Volume: 137, Issue:40 Topics: Acetamides; Administration, Oral; Antihypertensive Agents; Benzamides; Drug Therapy, Combination; Early Medical Intervention; Epoprostenol; Humans; Hypertension, Pulmonary; Imatinib Mesylate; Piperazines; Pyrazines; Pyrazoles; Pyrimidines; Randomized Controlled Trials as Topic; Sulfonamides	2012
Successful transition from Treprostinil to Selexipag in patient with severe pulmonary arterial hypertension. BMC pulmonary medicine, 2017, Oct-26, Volume: 17, Issue:1 Topics: Acetamides; Adult; Antihypertensive Agents; Drug Therapy, Combination; Epoprostenol; Exercise Tolerance; Familial Primary Pulmonary Hypertension; Female; Hemodynamics; Humans; Prospective Studies; Pyrazines; Pyrimidines; Sulfonamides	2017
[Triple combination therapy with macitentan, riociguat, and selexipag in a patient with idiopathic pulmonary arterial hypertension (functional class III)]. Kardiologiia, 2021, Oct-30, Volume: 61, Issue:10 Topics: Acetamides; Antihypertensive Agents; Familial Primary Pulmonary Hypertension; Female; Humans; Pyrazines; Pyrazoles; Pyrimidines; Sulfonamides	2021